PTC Therapeutics Inc (PTCT)
34.16
+2.01
(+6.25%)
USD |
NASDAQ |
May 01, 16:00
34.13
-0.03
(-0.09%)
Pre-Market: 20:00
PTC Therapeutics Cash from Operations (Quarterly): 70.76M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 70.76M |
| December 31, 2023 | -100.29M |
| September 30, 2023 | -14.52M |
| June 30, 2023 | -14.12M |
| March 31, 2023 | -29.49M |
| December 31, 2022 | -165.96M |
| September 30, 2022 | -38.04M |
| June 30, 2022 | -55.24M |
| March 31, 2022 | -97.40M |
| December 31, 2021 | -68.84M |
| September 30, 2021 | -51.19M |
| June 30, 2021 | -31.14M |
| March 31, 2021 | -100.16M |
| December 31, 2020 | -64.37M |
| September 30, 2020 | 26.66M |
| June 30, 2020 | -74.81M |
| March 31, 2020 | -81.55M |
| December 31, 2019 | -10.21M |
| September 30, 2019 | -15.50M |
| June 30, 2019 | -30.52M |
| March 31, 2019 | -42.41M |
| December 31, 2018 | -15.14M |
| September 30, 2018 | 3.377M |
| June 30, 2018 | 0.003M |
| March 31, 2018 | -15.88M |
| Date | Value |
|---|---|
| December 31, 2017 | 21.29M |
| September 30, 2017 | -15.77M |
| June 30, 2017 | 13.32M |
| March 31, 2017 | -28.90M |
| December 31, 2016 | -13.32M |
| September 30, 2016 | -24.08M |
| June 30, 2016 | -24.58M |
| March 31, 2016 | -41.59M |
| December 31, 2015 | -30.33M |
| September 30, 2015 | -27.76M |
| June 30, 2015 | -29.82M |
| March 31, 2015 | -36.42M |
| December 31, 2014 | -7.993M |
| September 30, 2014 | -17.04M |
| June 30, 2014 | -18.81M |
| March 31, 2014 | -13.44M |
| December 31, 2013 | -14.46M |
| September 30, 2013 | -5.177M |
| June 30, 2013 | -19.44M |
| March 31, 2013 | -7.847M |
| December 31, 2012 | -11.04M |
| September 30, 2012 | -6.196M |
| June 30, 2012 | -14.12M |
| March 31, 2012 | -16.58M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-165.96M
Minimum
Dec 2022
70.76M
Maximum
Mar 2024
-47.30M
Average
-44.62M
Median
Cash from Operations (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -54.66M |
| Pfizer Inc | 5.24B |
| Catalyst Pharmaceuticals Inc | 55.65M |
| Geron Corp | -40.94M |
| Perspective Therapeutics Inc | -9.008M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -114.93M |
| Cash from Financing (Quarterly) | 0.54M |
| Free Cash Flow | -199.47M |
| Free Cash Flow Per Share (Quarterly) | 0.0838 |
| Free Cash Flow to Equity (Quarterly) | 1.820B |
| Free Cash Flow to Firm (Quarterly) | 50.56M |
| Free Cash Flow Yield | -7.73% |